Analysts’ Viewpoint
Significant benefits, such as quick recovery and reduced inpatient hospital cost, across a broad range of surgical disciplines is driving the global minimally invasive surgery market. Scientific innovations and technological advancements in surgery have enabled the development of new minimally invasive procedures. Increase in popularity of robotic surgery due to precision and limited human intervention is another factor propelling market development. Furthermore, increase in preference for endoscopic surgeries, such as endoscopic mucosal resection and endoscopic submucosal dissection in gastrointestinal cancer treatment, is likely to bolster market expansion.
Development of new materials, such as memory metals, for the manufacturing of equipment to make heat activated scissors or forceps offers lucrative opportunities to market players. Manufacturers are focusing on developing advanced surgical robots with enhanced precision and control in order to increase market share.
Minimally invasive surgery (MIS), also known as minimally invasive procedure, refers to a surgical technique that is performed using small incisions or natural body openings instead of larger incisions required in traditional open surgeries. The goal of minimally invasive surgery is to minimize trauma to the body, reduce post-operative pain, accelerate recovery, and improve cosmetic outcomes.
Specialized surgical instruments and laparoscopes are used in a minimally invasive surgery. Laparoscope is a long, thin tube with a camera and light source attached to it, which allows a surgeon to visualize the surgical site on a monitor. Other surgical instruments are inserted through small incisions or ports, enabling the surgeon to perform the necessary procedures.
Robotic procedures represent the latest development in minimally invasive procedures, providing surgeons with precision devices that employ the same small incisions as conventional laparoscopy. A key difference is that the robotic systems can offer broader visualization of the operative field and precision control of minimally invasive surgery devices.
Less surgical pain, faster functional recovery, and shorter hospital stay are the major advantages of minimally invasive surgery (MIS) over open surgery.
Minimally invasive procedures are also associated with significantly less blood loss, lower analgesic consumption, faster time to first flatus, soft diet, and shorter postoperative hospital stay compared to open surgery. Awareness about the benefits of minimally invasive surgeries is increasing among patients.
Surgery is the only known treatment option for gastric cancer. Benefits of MIS procedure has encouraged octogenarians and older patients who face high operative morbidity and mortality to undergo surgery rather than strictly conservative treatment.
Usage of surgical robots in performing complex procedures is a significant factor bolstering global minimally invasive surgery market size. Surgical robots, such as the da Vinci Surgical System, have revolutionized the field of surgery by providing enhanced precision, dexterity, and control to surgeons during minimally invasive procedures.
Technological improvements, such as more efficient motors, compact & light materials, power back-up & sophisticated controls, and safety mechanisms, have led to development of cost-effective versions of surgical robots.
High precision of robot-assisted surgery helps in accurate implant positioning and reduces the risk of injury to adjacent tissues. Patients also benefit from less bleeding and post-operative pain, and fewer hospital readmissions.
Robots are also becoming increasingly important in the field of minimally invasive surgery due to the growing complexity of procedures to treat difficult diseases. With 38% of treatments involving thyroid cancer and 27.8% involving prostate cancer, respectively, robotic surgery is preferred for these procedures.
Thus, robotic surgery, which is gaining popularity among surgeons, is an efficient and secure way to treat thyroid and prostate cancer.
According to Cleveland Clinic, on average, around 35% of all colorectal surgeries in Atlanta, the U.S. have been performed robotically for the past two to three years.
In terms of procedure, the laparoscopic surgery segment dominated the global market in 2022, and the trend is expected to continue during the forecast period. This can be ascribed to higher rate of adoption of laparoscopy procedures to help diagnose different medical conditions that arise within the abdomen or pelvis.
According to Cleveland Clinic, more than 15 million laparoscopic procedures are performed globally every year. The number is expected to increase by 1% in the next five years. According to OECD, around 24,305 laparoscopic hysterectomy and 110,848 laparoscopic cholecystectomy surgeries have been performed in France.
Advanced laparoscopy devices are also used to perform surgical procedures such as removal of a diseased or damaged organ or a tissue sample for further testing (biopsy). Substantially low maintenance cost of laparoscopic handheld minimally invasive surgery devices and rise in technological innovations in handheld instruments are likely to augment the laparoscopic surgery segment during the forecast period.
Based on indication, the orthopedic surgery segment accounted for the largest global minimally invasive surgery market share in 2022. The trend is likely to continue during the forecast period.
An estimated 28.3 million orthopedic procedures were performed globally in 2022. The number is expected to increase during the forecast period. Therefore, high number of cases of orthopedic disorders, such as fracture of bones, bone cancer, is propelling demand for minimally invasive surgery across the globe.
In terms of end-user, the hospitals segment accounted for leading share of the global minimally invasive surgery market in 2022.
Rise in number of operating rooms in hospitals in developing countries, increase in patient preference for hospitals due to favorable reimbursement, availability to advanced minimally invasive surgery devices, and ability to perform different types of minimally invasive surgeries are expected to drive the hospitals segment during the forecast period. According to American Hospital Associations, the U.S. had more than 6,129 hospitals in 2022.
Europe accounted for the largest share of the global minimally invasive surgery market in 2022. The trend is projected to continue during the forecast period due to increase in the geriatric population in the region.
The market in Europe is driven by rise in prevalence of chronic diseases, focus on improving patient’s quality of life, and increase in healthcare expenditure. Increase in geriatric population is another key factor propelling demand for minimally invasive surgical instruments in the region. According to Eurostat, around 21.1%, one-fifth of the EU population, was aged 65 and over in 2022.
Asia Pacific is likely to be the fastest growing market for minimally invasive surgery during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2022 to 2031 due to large patient base in countries such as India and China and rise in awareness about MIS surgical procedure.
The global minimally invasive surgery market is fragmented, with the presence of large number of leading players. Manufactures of MIS devices are investing significantly in research & development, primarily to develop innovative new surgical devices. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the key players in the global minimally invasive surgery market.
Key players operating in the global market are Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Johnson & Johnson Services, Inc., Medtronic plc, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.
Key hospitals that have been also profiled in the report include Apollo Hospitals Enterprise Limited, Huntington Hospital, Johns Hopkins Hospital, Massachusetts General Hospital, Rutland Medical Center, Saint Michael's Hospital, Singapore General Hospital, The Ottawa Hospital, University of Pittsburgh Medical Center, and Washington Hospital Healthcare System.
The minimally invasive surgery market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US$ 231.1 Bn |
|
Forecast (Value) in 2031 |
US$ 301.1 Bn |
|
Growth Rate (CAGR) |
2.8% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Example: Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 231.1 Bn in 2022
It is projected to reach more than US$ 301.1 Bn by 2031
The business is anticipated to expand at a CAGR of 2.8% from 2023 to 2031
Increase in advantages of MIS over open surgeries and rise in demand for minimal invasive surgeries are likely to drive the market.
Europe is projected to account for major market share during the forecast period
Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Johnson & Johnson Services, Inc., Medtronic plc, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet are the prominent players in the market. Key hospitals that have been also profiled in the report include Apollo Hospitals Enterprise Limited, Huntington Hospital, Johns Hopkins Hospital, Massachusetts General Hospital, Rutland Medical Center
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Minimally Invasive Surgery Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics, by Region
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
5. Key Insights
5.1. Overview of reimbursement scenario for MIS surgeries by Region
5.1.1. Reimbursement Trends
5.2. Overview of pricing of MIS products
5.3. Data related to percentage of MIS adoption as compared to total procedures
5.4. Comparison between MIS and Open Surgery (Volume, by Region)
5.5. Information related MIS Training
5.5.1. MIS Training Gap
5.5.2. Verbatim about Training
5.6. Number of surgeons in each medical specialty and how many of them use MIS today (as per best-efforts basis)
5.7. List of procedures that can be done by MIS for each specialty
5.8. Cost of Surgery in Different Countries
5.9. Major Hospitals, by Region/Country
5.10. COVID-19 Impact Analysis
6. Global Minimally Invasive Surgery Market Analysis and Forecast, by Procedure
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
6.3.1. Laparoscopic Surgery
6.3.1.1. Orthopedic Surgery
6.3.1.2. Thoracic Surgery
6.3.1.3. Urology Surgery
6.3.1.4. Gynecology Surgery
6.3.1.5. Vascular Surgery
6.3.1.6. General Surgery
6.3.1.7. Cancer Surgery
6.3.1.8. Breast Surgery
6.3.1.9. Ear, Nose, and Throat Surgery
6.3.1.10. Bariatric Surgery
6.3.2. Robotic Surgery
6.3.2.1. Orthopedic Surgery
6.3.2.2. Cardiac Surgery
6.3.2.3. Thoracic Surgery
6.3.2.4. Urology Surgery
6.3.2.5. Gynecology Surgery
6.3.2.6. Vascular Surgery
6.3.2.7. General Surgery
6.3.2.8. Cancer Surgery
6.3.2.9. Breast Surgery
6.3.2.10. Ear, Nose, and Throat Surgery
6.3.2.11. Bariatric Surgery
6.3.2.12. Cosmetic/Plastic Surgery
6.3.2.13. Neurosurgery
6.3.3. Endoscopic Mucosal Resection
6.3.4. Endoscopic Submucosal Dissection
6.3.5. Transcatheter
6.3.5.1. Cardiac Surgery
6.3.5.2. Vascular Surgery
6.3.5.3. Cancer Surgery
6.3.5.4. Bariatric Surgery
6.4. Global Minimally Invasive Surgery Market Attractiveness, by Procedure
7. Global Minimally Invasive Surgery Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
7.3.1. Orthopedic Surgery
7.3.1.1. Knee
7.3.1.2. Spine
7.3.1.3. Shoulder
7.3.1.4. Others
7.3.2. Cardiac Surgery
7.3.2.1. Mitral Valve
7.3.2.2. Aortic Valve
7.3.2.3. Structural Heart Disease
7.3.2.4. Tricuspid Valve
7.3.2.5. Others
7.3.3. General Surgery
7.3.3.1. Gastrointestinal Surgery
7.3.3.2. Hepatobiliary Pancreatic Surgery
7.3.4. Urology Surgery
7.3.5. Thoracic Surgery
7.3.6. Gynecology Surgery
7.3.7. Vascular Surgery
7.3.8. Cancer Surgery
7.3.9. Breast Surgery
7.3.10. Ear, Nose, and Throat Surgery
7.3.11. Bariatric Surgery
7.3.12. Cosmetic/Plastic Surgery
7.3.13. Neurosurgery
7.4. Global Minimally Invasive Surgery Market Attractiveness, by Disease Indication
8. Global Minimally Invasive Surgery Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.1.1. Orthopedic Surgery
8.3.1.2. Cardiac Surgery
8.3.1.3. Thoracic Surgery
8.3.1.4. Urology Surgery
8.3.1.5. Gynecology Surgery
8.3.1.6. Vascular Surgery
8.3.1.7. General Surgery
8.3.1.8. Cancer Surgery
8.3.1.9. Breast Surgery
8.3.1.10. Ear, Nose, and Throat Surgery
8.3.1.11. Bariatric Surgery
8.3.1.12. Cosmetic/Plastic Surgery
8.3.1.13. Neurosurgery
8.3.2. Clinics
8.3.2.1. Orthopedic Surgery
8.3.2.2. Cardiac Surgery
8.3.2.3. Thoracic Surgery
8.3.2.4. Urology Surgery
8.3.2.5. Gynecology Surgery
8.3.2.6. Vascular Surgery
8.3.2.7. General Surgery
8.3.2.8. Cancer Surgery
8.3.2.9. Breast Surgery
8.3.2.10. Ear, Nose, and Throat Surgery
8.3.2.11. Bariatric Surgery
8.3.2.12. Cosmetic/Plastic Surgery
8.3.2.13. Neurosurgery
8.3.3. Ambulatory Surgical Centers
8.3.3.1. Orthopedic Surgery
8.3.3.2. Cardiac Surgery
8.3.3.3. Thoracic Surgery
8.3.3.4. Urology Surgery
8.3.3.5. Gynecology Surgery
8.3.3.6. Vascular Surgery
8.3.3.7. General Surgery
8.3.3.8. Cancer Surgery
8.3.3.9. Breast Surgery
8.3.3.10. Ear, Nose, and Throat Surgery
8.3.3.11. Bariatric Surgery
8.3.3.12. Cosmetic/Plastic Surgery
8.3.3.13. Neurosurgery
8.3.4. Others
8.3.4.1. Orthopedic Surgery
8.3.4.2. Cardiac Surgery
8.3.4.3. Thoracic Surgery
8.3.4.4. Urology Surgery
8.3.4.5. Gynecology Surgery
8.3.4.6. Vascular Surgery
8.3.4.7. General Surgery
8.3.4.8. Cancer Surgery
8.3.4.9. Breast Surgery
8.3.4.10. Ear, Nose, and Throat Surgery
8.3.4.11. Bariatric Surgery
8.3.4.12. Cosmetic/Plastic Surgery
8.3.4.13. Neurosurgery
8.4. Global Minimally Invasive Surgery Market Attractiveness, by End-user
9. Global Minimally Invasive Surgery Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Minimally Invasive Surgery Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Minimally Invasive Surgery Market Attractiveness, by Region
10. North America Minimally Invasive Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
10.2.1. Laparoscopic Surgery
10.2.1.1. Orthopedic Surgery
10.2.1.2. Thoracic Surgery
10.2.1.3. Urology Surgery
10.2.1.4. Gynecology Surgery
10.2.1.5. Vascular Surgery
10.2.1.6. General Surgery
10.2.1.7. Cancer Surgery
10.2.1.8. Breast Surgery
10.2.1.9. Ear, Nose, and Throat Surgery
10.2.1.10. Bariatric Surgery
10.2.2. Robotic Surgery
10.2.2.1. Orthopedic Surgery
10.2.2.2. Cardiac Surgery
10.2.2.3. Thoracic Surgery
10.2.2.4. Urology Surgery
10.2.2.5. Gynecology Surgery
10.2.2.6. Vascular Surgery
10.2.2.7. General Surgery
10.2.2.8. Cancer Surgery
10.2.2.9. Breast Surgery
10.2.2.10. Ear, Nose, and Throat Surgery
10.2.2.11. Bariatric Surgery
10.2.2.12. Cosmetic/Plastic Surgery
10.2.2.13. Neurosurgery
10.2.3. Endoscopic Mucosal Resection
10.2.4. Endoscopic Submucosal Dissection
10.2.5. Transcatheter
10.2.5.1. Cardiac Surgery
10.2.5.2. Vascular Surgery
10.2.5.3. Cancer Surgery
10.2.5.4. Bariatric Surgery
10.3. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
10.3.1. Orthopedic Surgery
10.3.1.1. Knee
10.3.1.2. Spine
10.3.1.3. Shoulder
10.3.1.4. Others
10.3.2. Cardiac Surgery
10.3.2.1. Mitral Valve
10.3.2.2. Aortic Valve
10.3.2.3. Structural Heart Disease
10.3.2.4. Tricuspid Valve
10.3.2.5. Others
10.3.3. General Surgery
10.3.3.1. Gastrointestinal Surgery
10.3.3.2. Hepatobiliary Pancreatic Surgery
10.3.4. Urology Surgery
10.3.5. Thoracic Surgery
10.3.6. Gynecology Surgery
10.3.7. Vascular Surgery
10.3.8. Cancer Surgery
10.3.9. Breast Surgery
10.3.10. Ear, Nose, and Throat Surgery
10.3.11. Bariatric Surgery
10.3.12. Cosmetic/Plastic Surgery
10.3.13. Neurosurgery
10.4. North America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.1.1. Orthopedic Surgery
10.4.1.2. Cardiac Surgery
10.4.1.3. Thoracic Surgery
10.4.1.4. Urology Surgery
10.4.1.5. Gynecology Surgery
10.4.1.6. Vascular Surgery
10.4.1.7. General Surgery
10.4.1.8. Cancer Surgery
10.4.1.9. Breast Surgery
10.4.1.10. Ear, Nose, and Throat Surgery
10.4.1.11. Bariatric Surgery
10.4.1.12. Cosmetic/Plastic Surgery
10.4.1.13. Neurosurgery
10.4.2. Clinics
10.4.2.1. Orthopedic Surgery
10.4.2.2. Cardiac Surgery
10.4.2.3. Thoracic Surgery
10.4.2.4. Urology Surgery
10.4.2.5. Gynecology Surgery
10.4.2.6. Vascular Surgery
10.4.2.7. General Surgery
10.4.2.8. Cancer Surgery
10.4.2.9. Breast Surgery
10.4.2.10. Ear, Nose, and Throat Surgery
10.4.2.11. Bariatric Surgery
10.4.2.12. Cosmetic/Plastic Surgery
10.4.2.13. Neurosurgery
10.4.3. Ambulatory Surgical Centers
10.4.3.1. Orthopedic Surgery
10.4.3.2. Cardiac Surgery
10.4.3.3. Thoracic Surgery
10.4.3.4. Urology Surgery
10.4.3.5. Gynecology Surgery
10.4.3.6. Vascular Surgery
10.4.3.7. General Surgery
10.4.3.8. Cancer Surgery
10.4.3.9. Breast Surgery
10.4.3.10. Ear, Nose, and Throat Surgery
10.4.3.11. Bariatric Surgery
10.4.3.12. Cosmetic/Plastic Surgery
10.4.3.13. Neurosurgery
10.4.4. Others
10.4.4.1. Orthopedic Surgery
10.4.4.2. Cardiac Surgery
10.4.4.3. Thoracic Surgery
10.4.4.4. Urology Surgery
10.4.4.5. Gynecology Surgery
10.4.4.6. Vascular Surgery
10.4.4.7. General Surgery
10.4.4.8. Cancer Surgery
10.4.4.9. Breast Surgery
10.4.4.10. Ear, Nose, and Throat Surgery
10.4.4.11. Bariatric Surgery
10.4.4.12. Cosmetic/Plastic Surgery
10.4.4.13. Neurosurgery
10.5. North America Minimally Invasive Surgery Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Minimally Invasive Surgery Market Attractiveness Analysis
10.6.1. By Procedure
10.6.2. By Disease Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Minimally Invasive Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
11.2.1. Laparoscopic Surgery
11.2.1.1. Orthopedic Surgery
11.2.1.2. Thoracic Surgery
11.2.1.3. Urology Surgery
11.2.1.4. Gynecology Surgery
11.2.1.5. Vascular Surgery
11.2.1.6. General Surgery
11.2.1.7. Cancer Surgery
11.2.1.8. Breast Surgery
11.2.1.9. Ear, Nose, and Throat Surgery
11.2.1.10. Bariatric Surgery
11.2.2. Robotic Surgery
11.2.2.1. Orthopedic Surgery
11.2.2.2. Cardiac Surgery
11.2.2.3. Thoracic Surgery
11.2.2.4. Urology Surgery
11.2.2.5. Gynecology Surgery
11.2.2.6. Vascular Surgery
11.2.2.7. General Surgery
11.2.2.8. Cancer Surgery
11.2.2.9. Breast Surgery
11.2.2.10. Ear, Nose, and Throat Surgery
11.2.2.11. Bariatric Surgery
11.2.2.12. Cosmetic/Plastic Surgery
11.2.2.13. Neurosurgery
11.2.3. Endoscopic Mucosal Resection
11.2.4. Endoscopic Submucosal Dissection
11.2.5. Transcatheter
11.2.5.1. Cardiac Surgery
11.2.5.2. Vascular Surgery
11.2.5.3. Cancer Surgery
11.2.5.4. Bariatric Surgery
11.3. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
11.3.1. Orthopedic Surgery
11.3.1.1. Knee
11.3.1.2. Spine
11.3.1.3. Shoulder
11.3.1.4. Others
11.3.2. Cardiac Surgery
11.3.2.1. Mitral Valve
11.3.2.2. Aortic Valve
11.3.2.3. Structural Heart Disease
11.3.2.4. Tricuspid Valve
11.3.2.5. Others
11.3.3. General Surgery
11.3.3.1. Gastrointestinal Surgery
11.3.3.2. Hepatobiliary Pancreatic Surgery
11.3.4. Urology Surgery
11.3.5. Thoracic Surgery
11.3.6. Gynecology Surgery
11.3.7. Vascular Surgery
11.3.8. Cancer Surgery
11.3.9. Breast Surgery
11.3.10. Ear, Nose, and Throat Surgery
11.3.11. Bariatric Surgery
11.3.12. Cosmetic/Plastic Surgery
11.3.13. Neurosurgery
11.4. Europe Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.1.1. Orthopedic Surgery
11.4.1.2. Cardiac Surgery
11.4.1.3. Thoracic Surgery
11.4.1.4. Urology Surgery
11.4.1.5. Gynecology Surgery
11.4.1.6. Vascular Surgery
11.4.1.7. General Surgery
11.4.1.8. Cancer Surgery
11.4.1.9. Breast Surgery
11.4.1.10. Ear, Nose, and Throat Surgery
11.4.1.11. Bariatric Surgery
11.4.1.12. Cosmetic/Plastic Surgery
11.4.1.13. Neurosurgery
11.4.2. Clinics
11.4.2.1. Orthopedic Surgery
11.4.2.2. Cardiac Surgery
11.4.2.3. Thoracic Surgery
11.4.2.4. Urology Surgery
11.4.2.5. Gynecology Surgery
11.4.2.6. Vascular Surgery
11.4.2.7. General Surgery
11.4.2.8. Cancer Surgery
11.4.2.9. Breast Surgery
11.4.2.10. Ear, Nose, and Throat Surgery
11.4.2.11. Bariatric Surgery
11.4.2.12. Cosmetic/Plastic Surgery
11.4.2.13. Neurosurgery
11.4.3. Ambulatory Surgical Centers
11.4.3.1. Orthopedic Surgery
11.4.3.2. Cardiac Surgery
11.4.3.3. Thoracic Surgery
11.4.3.4. Urology Surgery
11.4.3.5. Gynecology Surgery
11.4.3.6. Vascular Surgery
11.4.3.7. General Surgery
11.4.3.8. Cancer Surgery
11.4.3.9. Breast Surgery
11.4.3.10. Ear, Nose, and Throat Surgery
11.4.3.11. Bariatric Surgery
11.4.3.12. Cosmetic/Plastic Surgery
11.4.3.13. Neurosurgery
11.4.4. Others
11.4.4.1. Orthopedic Surgery
11.4.4.2. Cardiac Surgery
11.4.4.3. Thoracic Surgery
11.4.4.4. Urology Surgery
11.4.4.5. Gynecology Surgery
11.4.4.6. Vascular Surgery
11.4.4.7. General Surgery
11.4.4.8. Cancer Surgery
11.4.4.9. Breast Surgery
11.4.4.10. Ear, Nose, and Throat Surgery
11.4.4.11. Bariatric Surgery
11.4.4.12. Cosmetic/Plastic Surgery
11.4.4.13. Neurosurgery
11.5. Europe Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Minimally Invasive Surgery Market Attractiveness Analysis
11.6.1. By Procedure
11.6.2. By Disease Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Minimally Invasive Surgery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
12.2.1. Laparoscopic Surgery
12.2.1.1. Orthopedic Surgery
12.2.1.2. Thoracic Surgery
12.2.1.3. Urology Surgery
12.2.1.4. Gynecology Surgery
12.2.1.5. Vascular Surgery
12.2.1.6. General Surgery
12.2.1.7. Cancer Surgery
12.2.1.8. Breast Surgery
12.2.1.9. Ear, Nose, and Throat Surgery
12.2.1.10. Bariatric Surgery
12.2.2. Robotic Surgery
12.2.2.1. Orthopedic Surgery
12.2.2.2. Cardiac Surgery
12.2.2.3. Thoracic Surgery
12.2.2.4. Urology Surgery
12.2.2.5. Gynecology Surgery
12.2.2.6. Vascular Surgery
12.2.2.7. General Surgery
12.2.2.8. Cancer Surgery
12.2.2.9. Breast Surgery
12.2.2.10. Ear, Nose, and Throat Surgery
12.2.2.11. Bariatric Surgery
12.2.2.12. Cosmetic/Plastic Surgery
12.2.2.13. Neurosurgery
12.2.3. Endoscopic Mucosal Resection
12.2.4. Endoscopic Submucosal Dissection
12.2.5. Transcatheter
12.2.5.1. Cardiac Surgery
12.2.5.2. Vascular Surgery
12.2.5.3. Cancer Surgery
12.2.5.4. Bariatric Surgery
12.3. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
12.3.1. Orthopedic Surgery
12.3.1.1. Knee
12.3.1.2. Spine
12.3.1.3. Shoulder
12.3.1.4. Others
12.3.2. Cardiac Surgery
12.3.2.1. Mitral Valve
12.3.2.2. Aortic Valve
12.3.2.3. Structural Heart Disease
12.3.2.4. Tricuspid Valve
12.3.2.5. Others
12.3.3. General Surgery
12.3.3.1. Gastrointestinal Surgery
12.3.3.2. Hepatobiliary Pancreatic Surgery
12.3.4. Urology Surgery
12.3.5. Thoracic Surgery
12.3.6. Gynecology Surgery
12.3.7. Vascular Surgery
12.3.8. Cancer Surgery
12.3.9. Breast Surgery
12.3.10. Ear, Nose, and Throat Surgery
12.3.11. Bariatric Surgery
12.3.12. Cosmetic/Plastic Surgery
12.3.13. Neurosurgery
12.4. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.1.1. Orthopedic Surgery
12.4.1.2. Cardiac Surgery
12.4.1.3. Thoracic Surgery
12.4.1.4. Urology Surgery
12.4.1.5. Gynecology Surgery
12.4.1.6. Vascular Surgery
12.4.1.7. General Surgery
12.4.1.8. Cancer Surgery
12.4.1.9. Breast Surgery
12.4.1.10. Ear, Nose, and Throat Surgery
12.4.1.11. Bariatric Surgery
12.4.1.12. Cosmetic/Plastic Surgery
12.4.1.13. Neurosurgery
12.4.2. Clinics
12.4.2.1. Orthopedic Surgery
12.4.2.2. Cardiac Surgery
12.4.2.3. Thoracic Surgery
12.4.2.4. Urology Surgery
12.4.2.5. Gynecology Surgery
12.4.2.6. Vascular Surgery
12.4.2.7. General Surgery
12.4.2.8. Cancer Surgery
12.4.2.9. Breast Surgery
12.4.2.10. Ear, Nose, and Throat Surgery
12.4.2.11. Bariatric Surgery
12.4.2.12. Cosmetic/Plastic Surgery
12.4.2.13. Neurosurgery
12.4.3. Ambulatory Surgical Centers
12.4.3.1. Orthopedic Surgery
12.4.3.2. Cardiac Surgery
12.4.3.3. Thoracic Surgery
12.4.3.4. Urology Surgery
12.4.3.5. Gynecology Surgery
12.4.3.6. Vascular Surgery
12.4.3.7. General Surgery
12.4.3.8. Cancer Surgery
12.4.3.9. Breast Surgery
12.4.3.10. Ear, Nose, and Throat Surgery
12.4.3.11. Bariatric Surgery
12.4.3.12. Cosmetic/Plastic Surgery
12.4.3.13. Neurosurgery
12.4.4. Others
12.4.4.1. Orthopedic Surgery
12.4.4.2. Cardiac Surgery
12.4.4.3. Thoracic Surgery
12.4.4.4. Urology Surgery
12.4.4.5. Gynecology Surgery
12.4.4.6. Vascular Surgery
12.4.4.7. General Surgery
12.4.4.8. Cancer Surgery
12.4.4.9. Breast Surgery
12.4.4.10. Ear, Nose, and Throat Surgery
12.4.4.11. Bariatric Surgery
12.4.4.12. Cosmetic/Plastic Surgery
12.4.4.13. Neurosurgery
12.5. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis
12.6.1. By Procedure
12.6.2. By Disease Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Minimally Invasive Surgery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
13.2.1. Laparoscopic Surgery
13.2.1.1. Orthopedic Surgery
13.2.1.2. Thoracic Surgery
13.2.1.3. Urology Surgery
13.2.1.4. Gynecology Surgery
13.2.1.5. Vascular Surgery
13.2.1.6. General Surgery
13.2.1.7. Cancer Surgery
13.2.1.8. Breast Surgery
13.2.1.9. Ear, Nose, and Throat Surgery
13.2.1.10. Bariatric Surgery
13.2.2. Robotic Surgery
13.2.2.1. Orthopedic Surgery
13.2.2.2. Cardiac Surgery
13.2.2.3. Thoracic Surgery
13.2.2.4. Urology Surgery
13.2.2.5. Gynecology Surgery
13.2.2.6. Vascular Surgery
13.2.2.7. General Surgery
13.2.2.8. Cancer Surgery
13.2.2.9. Breast Surgery
13.2.2.10. Ear, Nose, and Throat Surgery
13.2.2.11. Bariatric Surgery
13.2.2.12. Cosmetic/Plastic Surgery
13.2.2.13. Neurosurgery
13.2.3. Endoscopic Mucosal Resection
13.2.4. Endoscopic Submucosal Dissection
13.2.5. Transcatheter
13.2.5.1. Cardiac Surgery
13.2.5.2. Vascular Surgery
13.2.5.3. Cancer Surgery
13.2.5.4. Bariatric Surgery
13.3. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
13.3.1. Orthopedic Surgery
13.3.1.1. Knee
13.3.1.2. Spine
13.3.1.3. Shoulder
13.3.1.4. Others
13.3.2. Cardiac Surgery
13.3.2.1. Mitral Valve
13.3.2.2. Aortic Valve
13.3.2.3. Structural Heart Disease
13.3.2.4. Tricuspid Valve
13.3.2.5. Others
13.3.3. General Surgery
13.3.3.1. Gastrointestinal Surgery
13.3.3.2. Hepatobiliary Pancreatic Surgery
13.3.4. Urology Surgery
13.3.5. Thoracic Surgery
13.3.6. Gynecology Surgery
13.3.7. Vascular Surgery
13.3.8. Cancer Surgery
13.3.9. Breast Surgery
13.3.10. Ear, Nose, and Throat Surgery
13.3.11. Bariatric Surgery
13.3.12. Cosmetic/Plastic Surgery
13.3.13. Neurosurgery
13.4. Latin America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.1.1. Orthopedic Surgery
13.4.1.2. Cardiac Surgery
13.4.1.3. Thoracic Surgery
13.4.1.4. Urology Surgery
13.4.1.5. Gynecology Surgery
13.4.1.6. Vascular Surgery
13.4.1.7. General Surgery
13.4.1.8. Cancer Surgery
13.4.1.9. Breast Surgery
13.4.1.10. Ear, Nose, and Throat Surgery
13.4.1.11. Bariatric Surgery
13.4.1.12. Cosmetic/Plastic Surgery
13.4.1.13. Neurosurgery
13.4.2. Clinics
13.4.2.1. Orthopedic Surgery
13.4.2.2. Cardiac Surgery
13.4.2.3. Thoracic Surgery
13.4.2.4. Urology Surgery
13.4.2.5. Gynecology Surgery
13.4.2.6. Vascular Surgery
13.4.2.7. General Surgery
13.4.2.8. Cancer Surgery
13.4.2.9. Breast Surgery
13.4.2.10. Ear, Nose, and Throat Surgery
13.4.2.11. Bariatric Surgery
13.4.2.12. Cosmetic/Plastic Surgery
13.4.2.13. Neurosurgery
13.4.3. Ambulatory Surgical Centers
13.4.3.1. Orthopedic Surgery
13.4.3.2. Cardiac Surgery
13.4.3.3. Thoracic Surgery
13.4.3.4. Urology Surgery
13.4.3.5. Gynecology Surgery
13.4.3.6. Vascular Surgery
13.4.3.7. General Surgery
13.4.3.8. Cancer Surgery
13.4.3.9. Breast Surgery
13.4.3.10. Ear, Nose, and Throat Surgery
13.4.3.11. Bariatric Surgery
13.4.3.12. Cosmetic/Plastic Surgery
13.4.3.13. Neurosurgery
13.4.4. Others
13.4.4.1. Orthopedic Surgery
13.4.4.2. Cardiac Surgery
13.4.4.3. Thoracic Surgery
13.4.4.4. Urology Surgery
13.4.4.5. Gynecology Surgery
13.4.4.6. Vascular Surgery
13.4.4.7. General Surgery
13.4.4.8. Cancer Surgery
13.4.4.9. Breast Surgery
13.4.4.10. Ear, Nose, and Throat Surgery
13.4.4.11. Bariatric Surgery
13.4.4.12. Cosmetic/Plastic Surgery
13.4.4.13. Neurosurgery
13.5. Latin America Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Minimally Invasive Surgery Market Attractiveness Analysis
13.6.1. By Procedure
13.6.2. By Disease Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Minimally Invasive Surgery Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
14.2.1. Laparoscopic Surgery
14.2.1.1. Orthopedic Surgery
14.2.1.2. Thoracic Surgery
14.2.1.3. Urology Surgery
14.2.1.4. Gynecology Surgery
14.2.1.5. Vascular Surgery
14.2.1.6. General Surgery
14.2.1.7. Cancer Surgery
14.2.1.8. Breast Surgery
14.2.1.9. Ear, Nose, and Throat Surgery
14.2.1.10. Bariatric Surgery
14.2.2. Robotic Surgery
14.2.2.1. Orthopedic Surgery
14.2.2.2. Cardiac Surgery
14.2.2.3. Thoracic Surgery
14.2.2.4. Urology Surgery
14.2.2.5. Gynecology Surgery
14.2.2.6. Vascular Surgery
14.2.2.7. General Surgery
14.2.2.8. Cancer Surgery
14.2.2.9. Breast Surgery
14.2.2.10. Ear, Nose, and Throat Surgery
14.2.2.11. Bariatric Surgery
14.2.2.12. Cosmetic/Plastic Surgery
14.2.2.13. Neurosurgery
14.2.3. Endoscopic Mucosal Resection
14.2.4. Endoscopic Submucosal Dissection
14.2.5. Transcatheter
14.2.5.1. Cardiac Surgery
14.2.5.2. Vascular Surgery
14.2.5.3. Cancer Surgery
14.2.5.4. Bariatric Surgery
14.3. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
14.3.1. Orthopedic Surgery
14.3.1.1. Knee
14.3.1.2. Spine
14.3.1.3. Shoulder
14.3.1.4. Others
14.3.2. Cardiac Surgery
14.3.2.1. Mitral Valve
14.3.2.2. Aortic Valve
14.3.2.3. Structural Heart Disease
14.3.2.4. Tricuspid Valve
14.3.2.5. Others
14.3.3. General Surgery
14.3.3.1. Gastrointestinal Surgery
14.3.3.2. Hepatobiliary Pancreatic Surgery
14.3.4. Urology Surgery
14.3.5. Thoracic Surgery
14.3.6. Gynecology Surgery
14.3.7. Vascular Surgery
14.3.8. Cancer Surgery
14.3.9. Breast Surgery
14.3.10. Ear, Nose, and Throat Surgery
14.3.11. Bariatric Surgery
14.3.12. Cosmetic/Plastic Surgery
14.3.13. Neurosurgery
14.4. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.1.1. Orthopedic Surgery
14.4.1.2. Cardiac Surgery
14.4.1.3. Thoracic Surgery
14.4.1.4. Urology Surgery
14.4.1.5. Gynecology Surgery
14.4.1.6. Vascular Surgery
14.4.1.7. General Surgery
14.4.1.8. Cancer Surgery
14.4.1.9. Breast Surgery
14.4.1.10. Ear, Nose, and Throat Surgery
14.4.1.11. Bariatric Surgery
14.4.1.12. Cosmetic/Plastic Surgery
14.4.1.13. Neurosurgery
14.4.2. Clinics
14.4.2.1. Orthopedic Surgery
14.4.2.2. Cardiac Surgery
14.4.2.3. Thoracic Surgery
14.4.2.4. Urology Surgery
14.4.2.5. Gynecology Surgery
14.4.2.6. Vascular Surgery
14.4.2.7. General Surgery
14.4.2.8. Cancer Surgery
14.4.2.9. Breast Surgery
14.4.2.10. Ear, Nose, and Throat Surgery
14.4.2.11. Bariatric Surgery
14.4.2.12. Cosmetic/Plastic Surgery
14.4.2.13. Neurosurgery
14.4.3. Ambulatory Surgical Centers
14.4.3.1. Orthopedic Surgery
14.4.3.2. Cardiac Surgery
14.4.3.3. Thoracic Surgery
14.4.3.4. Urology Surgery
14.4.3.5. Gynecology Surgery
14.4.3.6. Vascular Surgery
14.4.3.7. General Surgery
14.4.3.8. Cancer Surgery
14.4.3.9. Breast Surgery
14.4.3.10. Ear, Nose, and Throat Surgery
14.4.3.11. Bariatric Surgery
14.4.3.12. Cosmetic/Plastic Surgery
14.4.3.13. Neurosurgery
14.4.4. Others
14.4.4.1. Orthopedic Surgery
14.4.4.2. Cardiac Surgery
14.4.4.3. Thoracic Surgery
14.4.4.4. Urology Surgery
14.4.4.5. Gynecology Surgery
14.4.4.6. Vascular Surgery
14.4.4.7. General Surgery
14.4.4.8. Cancer Surgery
14.4.4.9. Breast Surgery
14.4.4.10. Ear, Nose, and Throat Surgery
14.4.4.11. Bariatric Surgery
14.4.4.12. Cosmetic/Plastic Surgery
14.4.4.13. Neurosurgery
14.5. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Minimally Invasive Surgery Market Attractiveness Analysis
14.6.1. By Procedure
14.6.2. By Disease Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles (Hospitals)
15.2.1. Apollo Hospitals Enterprise Limited
15.2.1.1. Services Portfolio
15.2.1.2. SWOT Analysis
15.2.1.3. Strategic Overview
15.2.2. Huntington Hospital
15.2.2.1. Services Portfolio
15.2.2.2. SWOT Analysis
15.2.2.3. Strategic Overview
15.2.3. Johns Hopkins Hospital
15.2.3.1. Services Portfolio
15.2.3.2. SWOT Analysis
15.2.3.3. Strategic Overview
15.2.4. Massachusetts General Hospital
15.2.4.1. Services Portfolio
15.2.4.2. SWOT Analysis
15.2.4.3. Strategic Overview
15.2.5. Rutland Medical Center
15.2.5.1. Services Portfolio
15.2.5.2. SWOT Analysis
15.2.5.3. Strategic Overview
15.2.6. Saint Michael's Hospital
15.2.6.1. Services Portfolio
15.2.6.2. SWOT Analysis
15.2.6.3. Strategic Overview
15.2.7. Singapore General Hospital
15.2.7.1. Services Portfolio
15.2.7.2. SWOT Analysis
15.2.7.3. Strategic Overview
15.2.8. The Ottawa Hospital
15.2.8.1. Services Portfolio
15.2.8.2. SWOT Analysis
15.2.8.3. Strategic Overview
15.2.9. University of Pittsburgh Medical Center
15.2.9.1. Services Portfolio
15.2.9.2. SWOT Analysis
15.2.9.3. Strategic Overview
15.2.10. Washington Hospital Healthcare System
15.2.10.1. Services Portfolio
15.2.10.2. SWOT Analysis
15.2.10.3. Strategic Overview
15.3. Company Profiles (Instrument Providers)
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. B. Braun Melsungen AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Becton, Dickinson and Company
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Boston Scientific Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. CONMED Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Johnson & Johnson Services, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Medtronic plc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Smith & Nephew plc
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Stryker Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Zimmer Biomet
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 02: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 03: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 04: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 05: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 06: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 07: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 08: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 09: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 10: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 11: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 12: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 13: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 14: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 15: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 16: Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 17: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 18: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 19: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 20: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 21: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 22: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 23: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 24: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 25: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 26: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 27: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 28: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 29: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 30: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 31: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 32: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 33: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 34: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 35: Global Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Region, 2017-2031
Table 36: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 37: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 38: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 39: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 40: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 41: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 42: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 43: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 44: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 45: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 46: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 47: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 48: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 49: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 50: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 51: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 52: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 53: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 54: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 55: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 56: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 57: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 58: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 59: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery , 2017-2031
Table 60: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery , 2017-2031
Table 61: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 62: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 63: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 64: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 65: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 66: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 67: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 68: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 69: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 70: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 71: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 72: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 73: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 74: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 75: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 76: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 77: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 78: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 79: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 80: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 81: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 82: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 83: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 84: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 85: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 86: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 87: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 88: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 89: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 90: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 91: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 92: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 93: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery , 2017-2031
Table 94: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery , 2017-2031
Table 95: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 96: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 97: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 98: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 99: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 100: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 101: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 102: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 103: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 104: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 105: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 106: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 107: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 108: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 109: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 110: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 111: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 112: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 113: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 114: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 115: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 116: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 117: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 118: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 119: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 120: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 121: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 122: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 123: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 124: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 125: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 126: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 127: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 128: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 129: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery, 2017-2031
Table 130: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery, 2017-2031
Table 131: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 132: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 133: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 134: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 135: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 136: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 137: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 138: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 139: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 140: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 141: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 142: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 143: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 144: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 145: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 146: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 147: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 148: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 149: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 150: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 151: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031
Table 152: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 153: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 154: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 155: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 156: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 157: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 158: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 159: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 160: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 161: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 162: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 163: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 164: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 165: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 167: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 168: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 169: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 170: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery , 2017-2031
Table 171: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery , 2017-2031
Table 172: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 173: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 174: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 175: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 176: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 177: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 178: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 179: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 180: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 181: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 182: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 183: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 184: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 185: Middle East and Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 186: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
Table 187: Middle East And Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Procedure, 2017-2031
Table 188: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 189: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by Orthopedic Surgery, 2017-2031 1
Table 190: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 191: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Disease Indication, 2017-2031
Table 192: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by Cardiac Surgery, 2017-2031
Table 193: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Laparoscopic Surgery, by General Surgery, 2017-2031
Table 194: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 196: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 197: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 198: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 199: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Disease Indication, 2017-2031
Table 200: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Orthopedic Surgery, 2017-2031
Table 201: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by Cardiac Surgery, 2017-2031
Table 202: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Robotic Surgery, by General Surgery, 2017-2031
Table 203: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 204: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 205: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Disease Indication, 2017-2031
Table 206: Middle East & Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast for Transcatheter, by Cardiac Surgery, 2017-2031
Table 207: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 208: Middle East and Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
Table 209: Middle East And Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 210: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Disease Indication, 2017-2031
Table 211: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Orthopedic Surgery , 2017-2031
Table 212: Middle East And Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Orthopedic Surgery , 2017-2031
Table 213: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by Cardiac Surgery, 2017-2031
Table 214: Middle East And Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by Cardiac Surgery, 2017-2031
Table 215: Middle East and Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by General Surgery, 2017-2031
Table 216: Middle East And Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast, by General Surgery, 2017-2031
Table 217: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 218: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 219: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Hospitals, by Disease Indication, 2017-2031
Table 220: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 221: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Clinics, by Disease Indication, 2017-2031
Table 222: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 223: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Ambulatory Surgical Centers, by Disease Indication, 2017-2031
Table 224: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
Table 225: Middle East & Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast for Others, by Disease Indication, 2017-2031
List of Figures
Figure 01: Global Minimally Invasive Surgery Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Minimally Invasive Surgery Market Value Share, by Procedure (2022)
Figure 03: Global Minimally Invasive Surgery Market Value Share, by Disease Indication (2022)
Figure 04: Global Minimally Invasive Surgery Market Value Share, by End-user (2022)
Figure 05: Global Minimally Invasive Surgery Market Value Share, by Region (2022)
Figure 06: Global Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 07: Global Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 08: Global Minimally Invasive Surgery Market (US$ Mn), by Laparoscopic Surgery, 2017-2031
Figure 09: Global Minimally Invasive Surgery Market (US$ Mn), by Robotic Surgery, 2017-2031
Figure 10: Global Minimally Invasive Surgery Market (US$ Mn), by Endoscopic Mucosal Resection, 2017-2031
Figure 11: Global Minimally Invasive Surgery Market (US$ Mn), by Endoscopic Submucosal Dissection, 2017-2031
Figure 12: Global Minimally Invasive Surgery Market (US$ Mn), by Transcatheter, 2017-2031
Figure 13: Global Minimally Invasive Surgery Market, by Disease Indication, 2022 and 2031
Figure 14: Global Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication, 2023-2031
Figure 15: Global Minimally Invasive Surgery Market (US$ Mn), by Orthopedic Surgery, 2017-2031
Figure 16: Global Minimally Invasive Surgery Market (US$ Mn), by Cardiac Surgery, 2017-2031
Figure 17: Global Minimally Invasive Surgery Market (US$ Mn), by General Surgery, 2017-2031
Figure 18: Global Minimally Invasive Surgery Market (US$ Mn), Urology Surgery, 2017-2031
Figure 19: Global Minimally Invasive Surgery Market (US$ Mn), by Thoracic Surgery, 2017-2031
Figure 20: Global Minimally Invasive Surgery Market (US$ Mn), by Gynecology Surgery, 2017-2031
Figure 21: Global Minimally Invasive Surgery Market (US$ Mn), by Vascular Surgery, 2017-2031
Figure 22: Global Minimally Invasive Surgery Market (US$ Mn), by Cancer Surgery, 2017-2031
Figure 23: Global Minimally Invasive Surgery Market (US$ Mn), by Breast Surgery, 2017-2031
Figure 24: Global Minimally Invasive Surgery Market (US$ Mn), by Ear, Nose and Throat Surgery, 2017-2031
Figure 25: Global Minimally Invasive Surgery Market (US$ Mn), by Bariatric Surgery, 2017-2031
Figure 26: Global Minimally Invasive Surgery Market (US$ Mn), by Cosmetic/Plastic Surgery, 2017-2031
Figure 27: Global Minimally Invasive Surgery Market (US$ Mn), by Neurosurgery, 2017-2031
Figure 28: Global Minimally Invasive Surgery Market (US$ Mn), by Others, 2017-2031
Figure 29: Global Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 30: Global Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Figure 31: Global Minimally Invasive Surgery Market (US$ Mn), by Hospitals, 2017-2031
Figure 32: Global Minimally Invasive Surgery Market (US$ Mn), by Clinics 2017-2031
Figure 33: Global Minimally Invasive Surgery Market (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
Figure 34: Global Minimally Invasive Surgery Market (US$ Mn), by Others, 2017-2031
Figure 35: Global Minimally Invasive Surgery Market Value Share Analysis, by Region, 2022 and 2031
Figure 36: Global Minimally Invasive Surgery Market Attractiveness Analysis, by Region, 2023-2031
Figure 37: North America Minimally Invasive Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 38: North America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 39: North America Minimally Invasive Surgery Market Value Share Analysis, by Country, 2022 and 2031
Figure 40: North America Minimally Invasive Surgery Market Attractiveness Analysis, by Country, 2023-2031
Figure 41: North America Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 42: North America Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 43: North America Minimally Invasive Surgery Market, by Disease Indication, 2022 and 2031
Figure 44: North America Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication , 2023-2031
Figure 45: North America Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 46: North America Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Figure 47: Europe Minimally Invasive Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 48: Europe Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 49: Europe Minimally Invasive Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 50: Europe Minimally Invasive Surgery Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 51: Global Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 52: Europe Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 53: Europe Minimally Invasive Surgery Market, by Disease Indication , 2022 and 2031
Figure 54: Europe Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication , 2023-2031
Figure 55: Europe Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 56: Europe Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Figure 57: Asia Pacific Minimally Invasive Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 58: Asia Pacific Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 59: Asia Pacific Minimally Invasive Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 60: Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis, by Country/Sub-region, 2022 and 2031
Figure 61: Asia Pacific Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 62: Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 63: Asia Pacific Minimally Invasive Surgery Market, by Disease Indication , 2022 and 2031
Figure 64: Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication , 2023-2031
Figure 65: Asia Pacific Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 66: Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Figure 67: Latin America Minimally Invasive Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 68: Latin America Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 69: Latin America Minimally Invasive Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 70: Latin America Minimally Invasive Surgery Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 71: Global Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 72: Latin America Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 73: Latin America Minimally Invasive Surgery Market, by Disease Indication , 2022 and 2031
Figure 74: Latin America Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication , 2023-2031
Figure 75: Latin America Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 76: Latin America Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Figure 77: Middle East And Africa Minimally Invasive Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 78: Middle East and Africa Minimally Invasive Surgery Market Volume (Mn Procedures) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 79: Middle East And Africa Minimally Invasive Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 80: Middle East And Africa Minimally Invasive Surgery Market Attractiveness Analysis, by Country/Sub-region, 2022 and 2031
Figure 81: Middle East and Africa Minimally Invasive Surgery Market, by Procedure, 2022 and 2031
Figure 82: Middle East and Africa Minimally Invasive Surgery Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 83: Middle East and Africa Minimally Invasive Surgery Market, by Disease Indication, 2022 and 2031
Figure 84: Middle East and Africa Minimally Invasive Surgery Market Attractiveness Analysis, by Disease Indication , 2023-2031
Figure 85: Middle East and Africa Minimally Invasive Surgery Market, by End-user, 2022 and 2031
Figure 86: Middle East and Africa Minimally Invasive Surgery Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Minimally Invasive Surgery Market
